Vialwirebiotech, curated
October 1, 2026, 4:37 PM
July 15, 2026
- 1:26 PM · STAT News
- 11:41 AM · BioPharma Dive11:41 AMMerck ADC, in China study, shows potential to replace chemo in lung cancer — BioPharma Dive
- 11:34 AM · BioPharma Dive11:34 AMBraveheart, Attovia join next wave of biotech IPOs — BioPharma Dive
- 10:17 AM · Pharmaceutical Executive10:17 AM<![CDATA[FDA Approves Revtorpyk for Treatment of Advanced HR-Positive, HER2-Negative Breast Cancer ]]> — Pharmaceutical Executive
- 10:03 AM · SCMP — Tech10:03 AMCUHK launches first cross-border clinical trial centre in Nansha — SCMP — Tech
- 10:00 AM · Drug Discovery World10:00 AMAre cell therapies the answer to age-related eye diseases? — Drug Discovery World
- 9:45 AM · Pharmaceutical Executive9:45 AM<![CDATA[Insilico Medicine Enters $2.5 Billion Alliance with Bora Pharmaceuticals ]]> — Pharmaceutical Executive
- 9:00 AM · BioWorld9:00 AMAtrium’s ATR-1072 gains IND clearance for PRKAG2 syndrome — BioWorld
- 9:00 AM · BioWorld9:00 AMVoyager’s gene therapy reduces tau levels in AD models — BioWorld
- 9:00 AM · BioWorld9:00 AMLyora Therapeutics launches with focus on retinal diseases — BioWorld
- 9:00 AM · BioWorld9:00 AMNampt inhibitors reported in Alphina Therapeutics patent — BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld
- 9:00 AM · BioWorld9:00 AMNuoshen Pharmaceutical prepares new NLRP3 inflammasome inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMBiocytogen Pharmaceuticals discloses new anti-DLL3/B7H3 ADCs — BioWorld
- 9:00 AM · BioWorld9:00 AMNeolaia identifies new CD38 inhibitors — BioWorld
- 9:00 AM · BioWorld9:00 AMSyndax Pharmaceuticals unveils new pipeline candidates — BioWorld
- 9:00 AM · BioWorld9:00 AMCancervax develops single polyepitope Smart mRNA — BioWorld
- 6:57 AM · Drug Discovery World6:57 AMUS$5m partnership targets Alzheimer’s and Parkinson’s biomarkers — Drug Discovery World
- 6:33 AM · Drug Discovery World6:33 AMCamena appoints CEO to scale antibody discovery platform — Drug Discovery World
- 5:50 AM · Pharmaceutical Technology5:50 AMFDA grants priority review to Roche’s Gazyva/Gazyvaro for pMN — Pharmaceutical Technology
- 5:33 AM · Drug Discovery World5:33 AMEvonik partners with evitria on protein expression kit — Drug Discovery World
July 14, 2026
- 8:27 PM · TechCrunch
- 5:35 PM · Pharmaceutical Executive5:35 PM<![CDATA[Steer Bio Targets Lymphedema with Regenerative Cell Therapy Platform]]> — Pharmaceutical Executive
- 12:20 PM · BioPharma Dive12:20 PMJudge orders Apple Tree partner to forfeit oversight of venture fund — BioPharma Dive
- 12:00 PM · BioWorld12:00 PMIsland Pharma targets Ebola species lacking approved treatments — BioWorld
- 12:00 PM · BioWorld12:00 PMDrug Farm bags $55M series D to advance AI-developed ALPK1 drug — BioWorld
- 12:00 PM · BioWorld12:00 PMAstrazeneca nabs PDE3/4 inhibitor for COPD in $2.1B Sino deal — BioWorld
- 12:00 PM · BioWorld12:00 PMHLB, Hengrui receive third US FDA rejection on liver cancer combo — BioWorld
- 12:00 PM · BioWorld12:00 PMMed-tech companies slapped with historic FTC penalty — BioWorld
- 12:00 PM · BioWorld12:00 PMTeva’s beef with Lilly over Forteo settlement lives again — BioWorld
- 12:00 PM · BioWorld12:00 PMTakeda's mezagitamab adds quality-of-life gains to ITP responses — BioWorld
- 12:00 PM · BioPharma Dive12:00 PMFresh off buyout, Akero execs reunite to advance long-acting psoriasis pill — BioPharma Dive
- 11:00 AM · BioWorld11:00 AMCelia trial: data strong, analysts skeptical — BioWorld
- 9:59 AM · BioPharma Dive9:59 AMDraig bags another $65M to speed testing of brain drugs — BioPharma Dive
- 9:24 AM · Pharmaceutical Executive9:24 AM<![CDATA[FDA Approves Leqembi Iqlik Subcutaneous Injection for Early Alzheimer’s Disease]]> — Pharmaceutical Executive
- 9:15 AM · STAT News
- 9:00 AM · BioWorld9:00 AMNiagen’s NB-4168 designated orphan drug in EU — BioWorld
- 9:00 AM · BioWorld9:00 AMPreclinical data support Evaxion’s platform behind CMV vaccine candidate — BioWorld
- 6:10 AM · Drug Discovery World6:10 AMInsilico Medicine and CMS announce CNS disease collaboration — Drug Discovery World
- 6:00 AM · Pharmaceutical Executive6:00 AM<![CDATA[The Origins of Nuvation Bio’s Deal with Daichii Sankyo for the Rights to Safusidenib in Japan]]> — Pharmaceutical Executive
- 5:30 AM · Drug Discovery World5:30 AMSofinnova Partners expands expertise with new partner — Drug Discovery World
- 5:10 AM · Drug Discovery World5:10 AMStudy proves preclinical efficacy of gene therapy for metabolic disorder — Drug Discovery World
- 4:57 AM · Pharmaceutical Technology4:57 AMNovartis and Chai Discovery collaborate on antibody identification — Pharmaceutical Technology
- 4:00 AM · Labiotech (EU)4:00 AMEnd-to-end: Curia drives supply and scale for steroid and hormonal therapies — Labiotech (EU)
- 3:39 AM · Pharmaceutical Technology3:39 AMCellares and Sonoma partner to automate cell therapy manufacturing — Pharmaceutical Technology
July 13, 2026
- 9:30 PM · FT — Pharmaceuticals9:30 PMDr Reddy’s runs into trouble with its weight-loss drug — FT — Pharmaceuticals
- 8:00 PM · Nature Biotechnology8:00 PMSangamo exits stage — Nature Biotechnology
- 5:25 PM · SCMP — Tech5:25 PMUS National Science Foundation to ban projects with flagged Chinese institutions — SCMP — Tech
- 4:58 PM · STAT News